In human HCC cells, the interaction of MDL800 with SIRT6 enhances SIRT6 deacetylase activity up to 22-fold, leading to a global decrease in the acetylation of H3K9 and H3K56. The gene discussed is SIRT6; the disease is hepatocellular carcinoma.